Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ·Healthcare·Biotechnology
$1.56
-0.32%
Mkt Cap $1.65M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$8.00
Range $8.00 – $8.00
Implied Upside
+414.5%
Consensus $8.00 vs current $1.56
NASDAQ·Healthcare·Biotechnology
$1.56
-0.32%
Mkt Cap $1.65M
No recent rating data.
Price Target (1 analysts)
$8.00
Range $8.00 – $8.00
+414.5%
Consensus $8.00 vs current $1.56